Best in Biotech 14 Nov 2024 8 biotech companies advancing new treatments for breast cancer in 2024 Delve into the diverse landscape of breast cancer treatment with nine biotech companies currently developing new treatments. November 14, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 Nov 2024 From consumer health to pure biopharma: Inside Sanofi’s strategic shift Delve into Sanofi’s “play to win” strategy as investments are ramping up after their consumer health division’s divestment. November 5, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 4 Nov 2024 Top biotech deals of October 2024 Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024. November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 31 Oct 2024 Five T cell engager companies you should know about Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off. October 31, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 30 Oct 2024 Spatial Transcriptomics: A window into disease The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease? October 30, 2024 - 11 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Oct 2024 GPCR therapies: Eight promising biotechs hacking the cell signaling pathway In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines. October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Oct 2024 Eight nanotechnology companies to watch out for Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about. October 22, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Oct 2024 The AI boom in cancer: Game-changer or just hype? Is AI just hype or a game-changer? Delve into AI’s contribution to oncology, from diagnostics to drug discovery and personalized treatment. October 18, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Oct 2024 Top six European biotech entrepreneurs to know in 2024 (according to VCs) We reached out to VCs to nominate prominent European entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market. October 17, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 16 Oct 2024 JAK inhibitors: Are they a good option for treating inflammatory diseases and cancer? Find out more about JAK inhibitors and whether they are a good option for treating inflammatory diseases and cancer. October 16, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 11 Oct 2024Bispecific ADCs: the next generation of cancer treatments To talk about bispecific ADCs, and biotechs in Czechia, our conversation this week is with Radek Špíšek, CEO of SOTIO. October 11, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Sponsored by Indivumed Therapeutics 8 Oct 2024 How an innovative, data-driven approach is revolutionizing drug discovery for solid tumors Learn how cancer tissue biobanks and insights into solid tumor heterogeneity are transforming drug discovery and paving the way for innovative treatments. October 8, 2024 - 6 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email